List of Tables
Table 1. Cognition-Enhancing Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Cognition-Enhancing Drugs Market Trends
Table 3. Cognition-Enhancing Drugs Market Drivers
Table 4. Cognition-Enhancing Drugs Market Challenges
Table 5. Cognition-Enhancing Drugs Market Restraints
Table 6. Global Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cognition-Enhancing Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Cognition-Enhancing Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Cognition-Enhancing Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Cognition-Enhancing Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Cognition-Enhancing Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Cognition-Enhancing Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Cognition-Enhancing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2021)
Table 18. Top Players of Cognition-Enhancing Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Cognition-Enhancing Drugs Product Type
Table 20. Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Cognition-Enhancing Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Cognition-Enhancing Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Cognition-Enhancing Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Cognition-Enhancing Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Cognition-Enhancing Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Cognition-Enhancing Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Cognition-Enhancing Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Cognition-Enhancing Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Cognition-Enhancing Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Cognition-Enhancing Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Cognition-Enhancing Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Accelerated Intelligence Corporation Information
Table 43. Accelerated Intelligence Description and Business Overview
Table 44. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Accelerated Intelligence Cognition-Enhancing Drugs Product
Table 46. Accelerated Intelligence Recent Development
Table 47. Cognition Therapeutics Corporation Information
Table 48. Cognition Therapeutics Description and Business Overview
Table 49. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Cognition Therapeutics Product
Table 51. Cognition Therapeutics Recent Development
Table 52. Cogstate Corporation Information
Table 53. Cogstate Description and Business Overview
Table 54. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Cogstate Product
Table 56. Cogstate Recent Development
Table 57. HVMN Corporation Information
Table 58. HVMN Description and Business Overview
Table 59. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. HVMN Product
Table 61. HVMN Recent Development
Table 62. Biogen Idec Corporation Information
Table 63. Biogen Idec Description and Business Overview
Table 64. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Biogen Idec Product
Table 66. Biogen Idec Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Cognition-Enhancing Drugs Customers List
Table 70. Cognition-Enhancing Drugs Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Cognition-Enhancing Drugs Product Picture
Figure 2. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
Figure 5. United States Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
Figure 8. United States Cognition-Enhancing Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Cognition-Enhancing Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Cognition-Enhancing Drugs Report Years Considered
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Global Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
Figure 17. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
Figure 23. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of Hospital Pharmacies
Figure 26. Product Picture of Drug Stores
Figure 27. Product Picture of Retail Pharmacies
Figure 28. Global Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
Figure 32. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
Figure 38. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Cognition-Enhancing Drugs Value Chain
Figure 74. Cognition-Enhancing Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
